Human Procollagen Type I C-Terminal Propeptide (PICP) Peptide (OVA)

Este producto es parte de PICP-Procollagen Type I C-Terminal Propeptide
Product Graph
494€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Procollagen Type I C-Terminal Propeptide (PICP) Peptide (OVA)
category
Proteins and Peptides
provider
Abbexa
reference
abx165593
tested applications
WB, SDS-PAGE

Description

Procollagen I C-Terminal Proprotein Protein is a Human protein.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Procollagen Type I C-Terminal Propeptide (PICP)
Host
Synthetic
Assay Type
Activity: Not tested
Sequence Fragment: Ser1193-Tyr1216
Origin
Human
Conjugation
OVA
Expression
Synthetic
Purity
> 90%
Size 1
100 µg
Size 2
200 µg
Size 3
500 µg
Size 4
1 mg
Size 5
5 mg
Form
Lyophilized
Tested Applications
WB, SDS-PAGE
Buffer
Prior to lyophilization: 10 mM PBS, pH 7.4.
Availability
Shipped within 5-7 working days.
Storage
Store lyophilized form at 2-8°C for up to 1 month. For longer periods, store lyophilized or liquid at -80°C. Avoid repeated freeze–thaw cycles.
Dry Ice
No
Alias
C-Propeptide Of Type I Procollagen,Procollagen I Carboxy Terminal Propeptide, P1CP
Background
Protein PICP
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
To keep the original salt concentration, we recommend reconstituting to the original concentration prior to lyophilization (see Concentration) in ddH2O. If a lower concentration is required, dilute in 10 mM PBS, pH 7.4. If a higher concentration is required, the product can be reconstituted directly in 10 mM PBS, pH 7.4, though please note that this will change the overall salt concentration. The stock concentration should be between 0.1-1.0 mg/ml. Do not vortex.
Concentration: Prior to lyophilization: 2.5 mg/ml

Descripción

Procollagen Type I C-Terminal Propeptide (PICP) is a cleavage product of type I procollagen, the precursor of type I collagen, which is the most abundant structural protein in the extracellular matrix of connective tissues. PICP is released into the bloodstream during the synthesis of type I collagen, making it a reliable biomarker for collagen synthesis and turnover. It is widely used in clinical and research settings to assess bone formation, as increased levels of PICP correlate with osteoblast activity and are indicative of bone remodeling or conditions such as osteoporosis and metabolic bone diseases. Elevated PICP levels can also occur in fibrotic conditions, including liver fibrosis, cardiac fibrosis, and certain cancers, reflecting excessive collagen deposition in affected tissues. Measurement of PICP is typically performed using immunoassays, and its levels can provide insight into the effectiveness of therapeutic interventions aimed at modulating collagen synthesis or tissue remodeling. Additionally, PICP is a key player in the assembly and stabilization of collagen fibrils, facilitating proper extracellular matrix organization. Dysregulation of PICP processing or collagen deposition can lead to pathological states, highlighting its importance in connective tissue health and disease.

Related Products

EH0957

Human PICP (C-terminal propeptide of Collagen alpha-1 (I) chain) ELISA Kit

Ver Producto
EM1290

Mouse PICP (Procollagen I C-terminal Propeptide) ELISA Kit

Ver Producto
ER0322

Rat PICP (C-terminal propeptide of Collagen alpha-1 (I) chain) ELISA Kit

Ver Producto